Organizations must adopt a comprehensive approach to address the growing cybersecurity challenges in healthcare. A comprehensive cybersecurity strategy must be multi-layered to address every potential ...

About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.

While Florida hospitals largely withstood the worst of the hurricane’s impacts, disruptions to public services could result in more patient transfers in the coming days.

The products include a service that helps healthcare organizations build their own AI agents that could be used for appointment scheduling, clinical trial matching and patient triage.

Here are the legal issues providers need to know as litigation increases around healthcare fraud and abuse, according to two experts.

While employers footed the bill for health plan price increases in 2024, they were largely unwilling to give employees access to popular weight loss drugs.

“The field of reproductive endocrinology is only 50 years old, and for 25 of those years RMA has been a clinical leader, setting a new standard of care for the industry,” added Dr. Thomas Molinaro, ...

More than half of respondents saw more procedure complications or reported poor outcomes due to care delays, while 28% said mortality rates rose.

Hospitals are contending with shortages of the life-saving supplies after Hurricane Helene damaged operations at a key manufacturing plant in North Carolina, according to the American Hospital ...

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer disclosed Wednesday. The downgrade could wipe out Humana’s profits in 2026.

For any data-driven initiative, quality is crucial. In medical imaging, this means ensuring data is accurate, complete, and consistently labeled. Poor-quality imaging data can lead to inefficient ...

Jason Stenta, who has held roles at Optum and CVS Health, joins as the company considers selling its stake in VillageMD and contends with shareholder litigation.